Evaluation of antibacterial activity of Australian basidiomycetous macrofungi using a high-throughput 96-well plate assay

References

• Al-Fatimi MA, Jülich WD, Jansen R, Lindequist U. (2006). Bioactive components of the traditionally used mushroom Podaxis pistillaris. Evid Based Complement Alternat Med 3:87–92.
   PubMed Web of Science ®Google Scholar
• Alfonso JA. (2005). Resistance toantibiotics: Are we in the post-antibiotic era? Arch Med Res 36:697–705.
   PubMed Web of Science ®Google Scholar
• Barros L, Calhelha RC, Vaz JA, Ferreira I, Baptista P, Estevinho LM. (2007). Antimicrobial activity and bioactive compounds of Portuguese wild edible mushrooms methanolic extracts. Eur Food Res Tech 225:151–156.
   Web of Science ®Google Scholar
• Barros L, Venturini BA, Baptista P, Estevinho LM, Ferreira IC. (2008). Chemical composition and biological properties of Portuguese wild mushrooms: A comprehensive study. J Agric Food Chem 56:3856–3862.
   PubMed Web of Science ®Google Scholar
• Beattie KD, Rouf R, Gander L, May TW, Ratkowsky D, Donner CD, Gill M, Grice ID, Tiralongo E. (2010). Antibacterial metabolites from Australian macrofungi from the genus Cortinarius. Phytochemistry 71:948–955.
   PubMed Web of Science ®Google Scholar
• Boa E. (2004). Wild edible fungi a global overview of their use and importance to people. Non-Wood Forest Products 17. Rome, Italy:FAO.
   Google Scholar
• Chang ST, Buswell JA. (1996). Mushroom nutriceuticals. World J Microbiol Biotech 12:473–476.
   PubMed Web of Science ®Google Scholar
• Costerton JW, Cheng KJ. (1975). The role of the bacterial cell envelope in antibiotic resistance. J Antimicrob Chemother 1:363–377.
   PubMedGoogle Scholar
• Drews J, Georgopoulos A, Laber G, Schütze E, Unger J. (1975). Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative. Antimicrob Agents Chemother 7:507–516.
   PubMed Web of Science ®Google Scholar
• Dulger B. (2004). Antimicrobial activity of the macrofungus Pholiota adiposa. Fitoterapia 75:395–397.
   PubMed Web of Science ®Google Scholar
• Dulger B, Gonuz A, Gucin F. (2004). Antimicrobial activity of the macrofungus Cantharellus cibarius. Pak J Biol Sci 7:1535–1539.
   Google Scholar
• Efremenkova OV, Ershova EY, Tolstych IV, Zenkova VA, Dudnik YV. (2003). Antimicrobial activity of medicinal mushrooms from the genus Coprinus (Fr.) S. F. Gray (Agaricomycetedeae). Int J Med Mush 5:37–41.
   Google Scholar
• Fleming A. (1929). On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol 10:226–236.
   Google Scholar
• Gbolagade J, Kigigha L, Ohimain E. (2007). Antagonistic effects of extracts of some Nigerian higher fungi against selected pathogenic microorganisms. Am-Eurasian J Agric Environ Sci 2:364–368.
   Google Scholar
• Gezer K, Duru ME, Kivrak I, Turkoglu A, Mercan N, Turkoglu H, Gulcan S. (2006). Free-radical scavenging capacity and antimicrobial activity of wild edible mushroom from Turkey. Afr J Biotech 5:1924–1928.
   Web of Science ®Google Scholar
• Hannan PC, Windsor HM, Ripley PH. (1997). In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae. Res Vet Sci 63:157–160.
   PubMed Web of Science ®Google Scholar
• Hawksworth DL. (2001). Mushrooms: The extent of the unexplored potential. Int J Med Mush 3:333–337.
   Google Scholar
• Hunt E. (2000). Pleuromutilin antibiotics. Drugs Fut 25:1163–1168.
   Web of Science ®Google Scholar
• Infectious Diseases Society of America. (2010). The 10 × ‘20 Initiative: Pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis 50:1081–1083.
   PubMed Web of Science ®Google Scholar
• Iwalokun BA, Usen UA, Otunba AA, Olukoya DK. (2007). Comparative phytochemical evaluation, antimicrobial and antioxidant properties of Pleurotus ostreatus. Afr J Biotech 6:1732–1739.
   Google Scholar
• Janes D, Kreft S, Jurc M, Seme K, Strukelj B. (2007). Antibacterial activity in higher fungi (mushrooms) and endophytic fungi from Slovenia. Pharm Biol 45:700–706.
   Web of Science ®Google Scholar
• Jonathan SG, Fasidi IO. (2003). Antimicrobial activities of two Nigerian edible macrofungi Lycoperdon pusilum (Bat. Ex) and Lycoperdon giganteum (Pers.). Afr J Biomed Res 6:85–90.
   Google Scholar
• Jones RN, Fritsche TR, Sader HS, Ross JE. (2006). Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant Gram-positive cocci. Antimicrob Agents Chemother 50:2583–2586.
   PubMed Web of Science ®Google Scholar
• Jones RN, Pfaller MA, Rhomberg PR, Walter DH. (2002). Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: initial development of in vitro susceptibility test methods. J Clin Microbiol 40:461–465.
   PubMed Web of Science ®Google Scholar
• Kalotas AC. (1996). Aboriginal knowledge and use of fungi. Fungi Aust 1B:268–295.
   Google Scholar
• Karaman M, Mimica-Dukic N, Knežević P, Svirčev Z, Matavuly M. (2009). Antibacterial properties of selected lignicolous mushrooms and fungi from northern Serbia. Int J Med Mush 11:269–279.
   Web of Science ®Google Scholar
• Kavanagh F, Hervey A, Robbins WJ. (1951). Antibiotic substances from Basidiomycetes: VIII. Pleurotus multilus (Fr.) Sacc. and Pleurotus passeckerianus Pilat. Proc Natl Acad Sci USA 37:570–574.
   PubMed Web of Science ®Google Scholar
• Keller C, Maillard M, Keller J, Hostettmann K. (2002). Screening of European fungi for antibacterial, antifungal, larvicidal, molluscicidal, antioxidant and free-radical scavenging activities and subsequent isolation of bioactive compounds. Pharm Biol 40:518–525.
   Web of Science ®Google Scholar
• Levy SB, Marshall B. (2004). Antibacterial resistance worldwide: Causes, challenges and responses. Nat Med 10:S122–S129.
   PubMed Web of Science ®Google Scholar
• Lindequist U, Niedermeyer TH, Jülich WD. (2005). The pharmacological potential of mushrooms. Evid Based Complement Alternat Med 2:285–299.
   PubMed Web of Science ®Google Scholar
• Liu XT, Winkler AL, Schwan WR, Volk TJ, Rott M, Monte A. (2010). Antibacterial compounds from mushrooms II: lanostane triterpenoids and an ergostane steroid with activity against Bacillus cereus isolated from Fomitopsis pinicola. Planta Med 76:464–466.
   PubMed Web of Science ®Google Scholar
• Lund RG, Del Pino FAB, Serpa R, Nascimento JSD, DA Silva VM, Ribeiro GA, Rosalen PL. (2009). Antimicrobial activity of ethanol extracts of Agaricus brasiliensis against mutans streptococci. Pharm Biol 47:910–915.
   Web of Science ®Google Scholar
• May TW. (2003). The status of names and records of Australian macrofungi. N Z J Bot 41:379–389.
   Web of Science ®Google Scholar
• Molitoris HP. (1994). Mushrooms in medicine. Folia Microbiol (Praha) 39:91–98.
   PubMed Web of Science ®Google Scholar
• Novak R, Shlaes DM. (2010). The pleuromutilin antibiotics: A new class for human use. Curr Opin Investig Drugs 11:182–191.
   PubMed Web of Science ®Google Scholar
• Ovenden SP, Yu J, Bernays J, Wan SS, Christophidis LJ, Sberna G, Tait RM, Wildman HG, Lebeller D, Platel D, May TW, Meurer-Grimes BM. (2005). Cerylimycins [corrected] A and B: Antibacterial triterpenes from the new species Tricholoma sp. AU1. J Nat Prod 68:409–412.
   PubMed Web of Science ®Google Scholar
• Popova M, Trusheva B, Gyosheva M, Tsvetkova I, Bankova V. (2009). Antibacterial triterpenes from the threatened wood-decay fungus Fomitopsis rosea. Fitoterapia 80:263–266.
   PubMed Web of Science ®Google Scholar
• Santoyo S, Ramirez-Anguiano AC, Reglero G, Soler-Rivas C. (2009). Improvement of the antimicrobial activity of edible mushroom extracts by inhibition of oxidative enzymes. Int J Food Sci Technol 44:1057–1064.
   Web of Science ®Google Scholar
• Stamets P. (2006). Can mushrooms help save the world? Explore 2:152–161.
   Google Scholar
• Suay I, Arenal F, Asensio FJ, Basilio A, Cabello MA, Díez MT, García JB, del Val AG, Gorrochategui J, Hernández P, Peláez F, Vicente MF. (2000). Screening of basidiomycetes for antimicrobial activities. Antonie Van Leeuwenhoek 78:129–139.
   PubMed Web of Science ®Google Scholar
• Sultanbawa Y, Cusack A, Currie M, Davis C. (2009). An innovative microplate assay to facilitate the detection of antimicrobial activity in plant extracts. J Rapid Meth Auto Microbiol 17:519–534.
   Google Scholar
• Tambekar DH, Sonar TP, Khodke MV, Khante BS. (2006). The novel antimicrobials from two edible mushrooms: Agaricus bisporus and Pleurotus sajor caju. Int J Pharmacol 2:584–587.
   Google Scholar
• Walsh C. (2003). Antibiotics: Actions, Origins, Resistance. Washington, DC: ASM Press, p. 26.
   Google Scholar
• Wasser SP, Weis AL. (1999). Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: A modern perspective. Crit Rev Immunol 19:65–96.
   PubMed Web of Science ®Google Scholar
• Werner H, Laber G, Schütze E, Krasemann C, May P. (1978). In vitro activity of tiamulin (81.723 HFU), a new pleuromulin derivative, against clinically significant anaerobes. J Antibiot 31:756–760.
   PubMed Web of Science ®Google Scholar
• Xu P, Zhang YY, Sun YX, Liu JH, Yang B, Wang YZ, Wang YL. (2009). Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus. Chem Biol Drug Des 73:655–660.
   PubMed Web of Science ®Google Scholar
• Yamac M, Bilgili F. (2006). Antimicrobial activities of fruit bodies and/or mycelial cultures of some mushroom isolates. Pharm Biol 44:660–667.
   Web of Science ®Google Scholar